Cyclacel Pharmaceuticals Inc. buy Roth Mkm
Start price
19.12.23
/
50%
€0.22
Target price
19.12.24
€19.12
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 19.12.24. The prediction end date can be changed by Roth_Mkm at any time.Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cyclacel Pharmaceuticals Inc. | - | - |
iShares Core DAX® | -3.935% | -3.998% |
iShares Nasdaq 100 | -3.608% | -9.386% |
iShares Nikkei 225® | -4.513% | -8.017% |
iShares S&P 500 | -2.607% | -4.265% |
Comments by Roth_Mkm for this prediction
In the thread Cyclacel Pharmaceuticals Inc. diskutieren
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) had its price target raised by analysts at Roth Mkm from $16.00 to $21.00. They now have a "buy" rating on the stock.
Ratings data for CYCC provided by MarketBeat
Stopped prediction by Roth_Mkm for Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€0.22
03.05.24
03.05.24
€10.21
03.05.25
03.05.25
-
15.12.23
15.12.23